Could a wearable robot help people with amyotrophic lateral sclerosis (ALS) walk farther? A new study from Toho University in ...
A new AI model shows promise for predicting genetic ALS risk regardless of family history or known mutations. Capsule Networks can distinguish people with ALS from unaffected individuals, with a high ...
The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient ...
The ACT for ALS annually funds critical therapies, research, grants and a worldwide ecosystem to share biological data.
ARLINGTON, Va., Dec. 11, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has announced a first-of-its-kind directive requiring Medicare Advantage plans to approve coverage for ...
A novel treatment for amyotrophic lateral sclerosis (ALS) caused by mutations in a specific gene called CHCHD10 showed ...
Team Gleason also tries to provide extraordinary experiences for ALS patients while at the same time raising awareness about ...
CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the ...
Mayo Clinic researchers report encouraging early results from an experimental therapy targeting the genetic cause of a rare ...
For almost a decade, I’ve fought for a cure for a disease I don’t even have yet. In 2018, when my mom was dying of the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), I learned ...
A drug company will voluntarily stop selling a medicine that was bringing in hundreds of millions of dollars, keeping a promise the business made years earlier to people with the fatal condition ALS.
New hope could be on the horizon for ALS patients in the form of a "breakthrough" drug, researchers say. Neuvivo, a California biopharmaceutical company that develops therapies for neurodegenerative ...